Bayer's Shirell A. Gross Recognized as One of Savoy Magazine's 2018 Most Influential Black Lawyers

News provided by

Jul 09, 2018, 10:59 ET

WHIPPANY, N.J., July 9, 2018 /PRNewswire/ -- Shirell A. Gross, Esq., Vice-President and Head of Law for Bayer Pharmaceuticals, Radiology, has been recognized by Savoy Magazine as one of their 2018 Most Influential Black Lawyers.

The full listing, which appears in the newly released summer 2018 issue, comprises the "best of the best" of black lawyers who are partners within leading national law firms, as well as corporate and general counsel from Fortune 1000 corporations.

Shirell A. Gross, Esq., is Vice-President and Head of Law for Bayer Pharmaceuticals, Radiology. Savoy Magazine recently honored Gross as one of their 2018 Most Influential Black Lawyers in their newly released summer issue.

Gross leads the legal support for Bayer Radiology's commercial functions in the Americas and for its Product Supply, Regulatory, Quality and Informatics/Software licensing functions worldwide.

Prior to Bayer, Gross was with Quest Diagnostics counseling on commercial, compliance, medical/quality, risk management and litigation matters. She has also represented health care providers on professional liability matters with Aaronson, Rappaport, Feinstein and Deutsch. Gross started her legal career as an Assistant District Attorney in Bronx, N.Y.

Throughout her career, Gross has been committed to diversity, leadership development, mentoring and community service. She has received numerous awards for her service and frequently lectures on these topics both within Bayer and at external meetings and conferences.

"Shirell is an excellent lawyer, an outstanding leader and simply a great colleague," said Jan Heinemann, Head of Law, Patents and Compliance for Bayer in the U.S. "We at Bayer are fortunate to have her on the team, and we applaud her for garnering this well-deserved honor."

As diversity and inclusion for legal professionals continues to grow, Savoy's listing of "top lawyers" emerges with an influential cross section of legal professionals representing a diverse range of expertise with national and global responsibilities.

"We're honored to assemble the most powerful and impactful listing of lawyers working in corporate counsel & major law firms in the summer issue of Savoy," said L.P. Green, II, Publisher, Savoy Magazine. "African American men and women in the legal profession continue to reach new heights of achievement, and we endeavor to spotlight their success through our coverage of their work through the magazine. We congratulate and salute those selected in the 2018 Most Influential Black Lawyers listing.

"This issue focuses on the top lawyers, showcasing visionaries, leaders and advocates – including partners and counsel – within the legal profession who are widely recognized for their professionalism, protection of rights and community service," he said.

Bayer: Science for a Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2017, the Group employed around 99,800 people and had sales of EUR 35.0 billion. Capital expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5 billion. For more information, go to www.bayer.us.

Contact:

Dan Childs
Bayer U.S.
Email: [email protected]

Office: 862-404-7744

Mobile: 973-437-0809

Social Media Channels

- Facebook: BayerUnitedStates

- Twitter: BayerUS

- Instagram: BayerUS

- YouTube: BayerUS

Bayer® and the Bayer Cross® are registered trademarks of Bayer.

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

SOURCE Bayer